medical line

NG Bone

Bovine
Hydroxyapatite
Generic name:
bovine hydroxyapatite, hydroxyapatite mineral matrix of bovine origin for bone replacement and guided regeneration.

Composition/active substance:
hydroxiapatite of 100% bovine origin.

Presentations/models:
Granulometry:

CodeParticle size
N210 - 1000 µm
G1000 - 2000 µm
EG> 2000 µm
EG+840 - 2000 µm

In presentations of 5 ml; 10 ml; 20 ml.
Cortico-cancellous blocks, boards and wedges.
Spheres from 6 to 30 mm in diameter.

FEATURES

Biomaterial of bovine origin with a microstructure similar to that of mineralized human bone. It has a high porosity structure, which allows internal cell migration, favoring angiogenesis (formation of blood vessels) and osteogenesis (creation of new bone). The high-temperature BOS-HA® processing assures the complete removal of organic material present in native bovine bone, which eliminates possible immunogenic reactions. It offers the specialist surgeon the following properties:

Sterile, inert and biocompatible material
Hydrophilic
Osteoconductive
Due to its slow reabsorption rate, it behaves as an excellent support scaffold at the implant site, which preserves the volume of the graft in the long term.
Microstructure similar to that of human bone.
CLINICAL INDICATIONS
Its use is indicated in the following cases:
Bone substitute in medical surgeries.
Loss of bone substance, need for augmentation and filling of cavities that must be covered with bone tissue.
Filling of bone cavities in traumatology, dentistry and ophthalmology.
Bone reconstruction and regeneration in traumatology, dentistry and ophthalmology.
Bone reconstruction and regeneration in spinal surgery.
Filler in ocular evisceration and enucleation.
Filler material in the eye socket.
Cranioplasties.
Maxillofacial surgery.
Other clinical indications.

INSTRUCTIONS FOR USE

Moisten with sterile saline solution or the patient’s own blood before implantation.
Apply the material to the defect using sterile instruments.
Ensure optimal contact between the bone filling and the recipient bone in order to ensure correct osteoinduction.
Modulate with spatula, if necessary.
Avoid excess product in the defect.
Place a membrane to protect the soft tissue graft, in cases where this type of protection is required.
The implant specialist must take into account the strength of the bone filling when loading it and, where appropriate, placing a support structure.
Ensure the correct immobilization of the filling in order to avoid micro movements that could generate a fibrous encapsulation.
The surgical technique described must be carried out exclusively in an appropriate environment and with sterile instruments.

WARNINGS AND PRECAUTIONS

To facilitate bone neoformation, the implanted material must be in direct contact with bone walls with good vascularization and, in certain cases, it is recommended to prepare the patient’s bone tissue with a bur.

In the case of large cavities, a mixture of this biomaterial with autologous bone can improve neoformation.

  • Implantology (Dentistry): Experience shows that in areas where bone mass has increased, mechanical load or the definitive insertion of implants should not be applied until at least 4 to 6 months have elapsed from the insertion of the material.
  • Periodontics (Dentistry): Before applying the biomaterial, it is necessary to perform a correct treatment of the periodontal lesion by root scaling, curettage and other appropriate procedures.
  • Traumatology: In cases of large fillings, the final mechanical properties in the regenerated area may not be identical to those that would have been obtained with an autologous transplant.

 Discard any remnants and do not attempt to resterilize the biomaterial. Do not use after the expiration date.